Indian LED Lighting Market to Grow at a 32.15% CAGR Forecast to 2021

LED Lighting India Market Segmentation and Major Players Analysis and Forecast to 2021

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — Light Emitting Diodes (LEDs) have entered the lighting market, not even a decade before, as an energy efficient alternative to traditional light sources such as incandescent and fluorescent bulbs. These lights still have an enormous amount of room for technological growth and offer various advantages over all other forms of lighting. Having just recently entered the lighting market, LEDs have faced many barriers to entry and are struggling to obtain a market share over the traditional forms of lights. Compact fluorescent lamps (CFL) also used to be a disruptive technology, but it took over 20 years to achieve significant market share.
Request a sample report @ https://www.wiseguyreports.com/sample-request/744778-india-led-lighting-market-outlook-2021

India Lighting market is growing with a CAGR of 16.83% from last five years and is projected to grow even in future due to excellent growth in the LED Lighting industry. LED Lighting market is growing with a whopping CAGR of 57.31% over last five years. Government initiatives to replace incandescent bulbs with LED bulbs under various schemes, increasing energy demand in the country and declining prices of LED lights are the factors driving the growth of LED lighting in India.

According to “India LED Lighting Market Outlook 2021”, India’s LED Lighting market is forecast to grow at a CAGR of 32.15% over six years. LED Lighting, which accounts for 19% share in the current overall Lighting market, is anticipated to reach 62% by the year 2021. The report reveals that Philips, Surya Roshni, Osram, Bajaj, Havells, etc. are the leading players in India Lighting market and are expected to dominate the market in the forecast period also. The growing awareness about LED lighting in the Southern India has proved to be the important market for LED lighting companies. Street lighting application accounts for majority of the market revenues in India LED lighting market. Outdoor LED lighting segment is growing robustly on account of growing demand for LED installations in parks, streets, railways, metro stations, parking lots and other public places. “India LED Lighting Market Outlook 2021” discusses the following aspects of LED Lighting in India
Complete report details @ https://www.wiseguyreports.com/reports/744778-india-led-lighting-market-outlook-2021
Key points in table of content
1. Executive Summary
2. Global LED Lighting Market Outlook
2.1. Market Size – By Value
2.1.1. Lighting Market
2.1.2. LED Lighting Market
2.2. Market Share
2.2.1. By Region
2.2.2. By Application
2.2.3. By LED Technology
2.3. Pricing Analysis
3. India LED Lighting Market Outlook
3.1. Market Size – By Value
3.1.1. Lighting Market
3.1.2. LED lighting Market
3.2. Market Share
3.2.1. By Company
3.2.2. By Region
3.2.3. By Types
3.2.4. By Application
3.3. Pricing Analysis
4. Production Procedure
5. India Economic Profile 2014
6. Raw Material
7. Policy & Regulatory Landscape
8. Organized Vs Unorganized Market
9. PEST Analysis
10. India LED Lighting Market Trade Dynamics
10.1. Import
10.2. Export
11. Channel Partner Analysis
12. Market Dynamics
12.1. Key Drivers
12.2. Key Challenges
13. Market Trends & Developments
13.1. Outdoor Applications
13.2. Buying Trend in Metropolitan Cities
13.3. Indian Products Vs Imported Products
13.4. Thinner Smartphone Backlight LEDs
14. Competitive Landscape
14.1. Porter’s Five Forces
14.2. Company Profiles
14.2.1. Philips India Ltd.
14.2.2. Bajaj Electricals Ltd.
14.2.3. General Electric Company
14.2.4. Havells India Ltd.
14.2.5. Osram India Pvt. Ltd.
14.2.6. Syska Led Lights Pvt. Ltd.
14.2.7. Reiz India
14.2.8. Eveready Industries India Ltd.
14.2.9. Moser Baer India Ltd.
14.2.10. Crompton Greaves
15. Strategic Recommendations
16. Disclaimer
Get this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=744778
Contact US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Surgical Mesh : Medical Devices Pipeline Assessment, 2016



Wise.Guy.

Surgical Mesh Medical Devices Pipeline Assessment 2016

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Surgical Mesh pipeline products.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/729488-surgical-mesh-medical-devices-pipeline-assessment-2016

Scope
– Extensive coverage of the Surgical Mesh under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Surgical Mesh and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Surgical Mesh under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Surgical Mesh Overview 8
3 Products under Development 9
3.1 Surgical Mesh – Pipeline Products by Stage of Development 9
3.2 Surgical Mesh – Pipeline Products by Territory 10
3.3 Surgical Mesh – Pipeline Products by Regulatory Path 11
3.4 Surgical Mesh – Pipeline Products by Estimated Approval Date 12
3.5 Surgical Mesh – Ongoing Clinical Trials 13
4 Surgical Mesh – Pipeline Products under Development by Companies 14
4.1 Surgical Mesh Companies – Pipeline Products by Stage of Development 14
4.2 Surgical Mesh – Pipeline Products by Stage of Development 16
5 Surgical Mesh Companies and Product Overview 18
5.1 Acera Surgical, Inc. Company Overview 18
5.1.1 Acera Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Admedus Ltd Company Overview 19
5.2.1 Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 Anika Therapeutics, Inc. Company Overview 21
5.3.1 Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 Boston Scientific Corporation Company Overview 23
5.4.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 23
5.5 DSM Biomedical B.V. Company Overview 25
5.5.1 DSM Biomedical B.V. Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 Ethicon Inc Company Overview 29
5.6.1 Ethicon Inc Pipeline Products & Ongoing Clinical Trials Overview 29
5.7 Fibralign Corporation Company Overview 31
5.7.1 Fibralign Corporation Pipeline Products & Ongoing Clinical Trials Overview 31
5.8 Harbor MedTech, Inc. Company Overview 35
5.8.1 Harbor MedTech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.9 John Hopkins University Company Overview 38
5.9.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 38
5.10 Medisse BV Company Overview 39
5.10.1 Medisse BV Pipeline Products & Ongoing Clinical Trials Overview 39
5.11 Medlinx Acacia Pte Ltd Company Overview 41
5.11.1 Medlinx Acacia Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
5.12 Medtronic plc Company Overview 42
5.12.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 42
5.13 MiMedx Group, Inc Company Overview 44
5.13.1 MiMedx Group, Inc Pipeline Products & Ongoing Clinical Trials Overview 44
5.14 PolyNovo Biomaterials Pty Ltd Company Overview 46
5.14.1 PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
5.15 Proxy Biomedical Limited Company Overview 47
5.15.1 Proxy Biomedical Limited Pipeline Products & Ongoing Clinical Trials Overview 47
5.16 Retectix, LLC Company Overview 48
5.16.1 Retectix, LLC Pipeline Products & Ongoing Clinical Trials Overview 48
5.17 Revivicor, Inc. Company Overview 49
5.17.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.18 Samyang Biopharmaceuticals Corporation Company Overview 50
5.18.1 Samyang Biopharmaceuticals Corporation Pipeline Products & Ongoing Clinical Trials Overview 50
5.19 Soft Tissue Regeneration, Inc. Company Overview 51
5.19.1 Soft Tissue Regeneration, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.20 Teleflex Incorporated Company Overview 52
5.20.1 Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview 52
5.21 Tepha, Inc. Company Overview 54
5.21.1 Tepha, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.22 The Electrospinning Company Ltd Company Overview 55
5.22.1 The Electrospinning Company Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
5.23 University of Maryland, Baltimore Company Overview 56
5.23.1 University of Maryland, Baltimore Pipeline Products & Ongoing Clinical Trials Overview 56
5.24 University of South Florida Company Overview 57
5.24.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 57
6 Surgical Mesh- Recent Developments 58
6.1 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 58
6.2 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results 59
6.3 Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results 60
6.4 Oct 25, 2016: RTI Surgical Announces 2016 Third Quarter Results 61

Access Report @ https://www.wiseguyreports.com/reports/729488-surgical-mesh-medical-devices-pipeline-assessment-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Internet of Things (IoT) in Transportation Market to Grow at a 17%CAGR Forecast to 2020

Global Internet of Things (IoT) in Transportation Market 2016 Share, Trend, Segmentation and Forecast to 2020

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — Description

The report ‘Global Internet of Things (IoT) in Transportation Market by Technology (Navigation System, Telematics, Infotainment, ADAS, Semiconductor, Sensors) – Outlook 2020” provides an in-depth analysis of incorporation of IoT in transportation segment which is expected to grow at a CAGR of 17% in the forecasted period 2016-20. The report is segmented on the basis of major technologies used to enable this with detailed current and forecasted market outlook.

Request a sample report @ https://www.wiseguyreports.com/sample-request/721398-global-internet-of-things-sensors-outlook-2020

Growth of the industry is fuelled by emergence of driverless cars, enhanced safety feature with use of ADAS, Government support and higher efficiency in transportation and logistics with connectivity. However, rise of cyber threat with IoT in transportation, integration complexities of disparate systems and security and privacy risks associated with connectivity solutions are the major factors restraining the growth and adoption of IoT solutions in transportation segment. Global IoT Transportation market is dominated by few major companies, of which Alcatel Lucent, AT&T and Cisco Systems Inc have been profiled in the report.

Technological Coverage

• Navigation Systems
• Navigation Systems
• Automotive Semiconductor
• Telematics
• Infotainment
• ADAS
• Sensors

Key Vendors

• Alcatel-Lucent
• AT&T
• Cisco Systems

Complete report details @ https://www.wiseguyreports.com/reports/721398-global-internet-of-things-sensors-outlook-2020

Table Of Contents

Executive Summary

2. Research Methodology

3. Internet of Things

3.1 Overview
3.2 Market Size
3.3 Applications

4. IoT in Transportation Industry

4.1 Overview
4.1.1 Benefits of IoT in Transportation
4.2 Intelligent Transportation Systems (ITS)
4.2.1 ITS – Brief History
4.3 Market Size (Actual & Foreacsted)

5. IoT in Transportation by Technology

5.1 Navigation Systems

5.1.1 Overview
5.1.2 Market Size in Road Transport (Actual & Forecasted)
5.1.3 Market Size in Air Transport (Actual & Forecasted)
5.1.4 Market Size in Rail Transport (Actual & Forecasted)
5.1.5 Market Size in Maritime (Actual & Forecasted)

5.2 Automotive Semiconductor

5.2.1 Overview
5.2.2 Market Size (Actual & Forecasted)
5.2.3 Market Share by Category
5.2.4 Market Share by Competitors

5.3 Automotive Telematics

5.3.1 Overview
5.3.2 Market Size (Actual & Forecasted)
5.3.3 Market Share by Category

5.4 Automotive Infotainment

5.4.1 Overview
5.4.2 Market Size (Actual & Forecasted)
5.4.3 Market Share by Operating System
5.4.4 Market Share by Competitors

5.5 ADAS

5.5.1 Overview
5.5.2 Market Sizing (Actual & Forecasted)

5.6 Sensors

5.6.1 Overview
5.6.2 Market Size (Acutal & Forecasted)

5.7 RFID

5.8 NFC Technology

6. Market Dynamics

6.1 Growth Drivers

6.1.1 Emergence of Driverless Cars
6.1.2 Enhanced Safety Feature with ADAS
6.1.3 Government Support
6.1.4 Higher efficiency in Transportation & Logistics

6.2 Challenges

6.2.1 Rise of Cyber threat
6.2.2 Integration complexities
6.2.3 Security & Privacy Risk

7. Market Trends

7.1 Advent of Connected Cars
7.2 Intelligent Mobility
7.3 ‘Onboard Diagnostics’ in Logistics
7.4 High Positional accuracy for Automoblies using UDR

8. Competitive Landscape

10. Company Profiles

10.1 Alcatel Lucent

10.1.1 Business Overview
10.1.2 Financial Overview
10.1.3 Business Strategies

10.2 AT&T

10.2.1 Business Overview
10.2.2 Financial Overview
10.2.3 Business Strategies

10.3 Cisco Systems Inc

10.3.1 Business Overview
10.3.2 Financial Overview
10.3.3 Business Strategies

Get It Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=721398

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Minimally Invasive Surgical (MIS) Devices:Medical Devices Pipeline Assessment 2016



Wise.Guy.

Minimally Invasive Surgical (MIS) Devices Medical Devices Pipeline Assessment, 2016

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Minimally Invasive Surgical (MIS) Devices pipeline products.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/729487-minimally-invasive-surgical-mis-devices-medical-devices-pipeline-assessment-2016

Scope
– Extensive coverage of the Minimally Invasive Surgical (MIS) Devices under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Minimally Invasive Surgical (MIS) Devices and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Minimally Invasive Surgical (MIS) Devices under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 Minimally Invasive Surgical (MIS) Devices Overview 9
3 Products under Development 10
3.1 Minimally Invasive Surgical (MIS) Devices – Pipeline Products by Stage of Development 10
3.2 Minimally Invasive Surgical (MIS) Devices – Pipeline Products by Territory 11
3.3 Minimally Invasive Surgical (MIS) Devices – Pipeline Products by Regulatory Path 12
3.4 Minimally Invasive Surgical (MIS) Devices – Pipeline Products by Estimated Approval Date 13
3.5 Minimally Invasive Surgical (MIS) Devices – Ongoing Clinical Trials 14
4 Minimally Invasive Surgical (MIS) Devices – Pipeline Products under Development by Companies 15
4.1 Minimally Invasive Surgical (MIS) Devices Companies – Pipeline Products by Stage of Development 15
4.2 Minimally Invasive Surgical (MIS) Devices – Pipeline Products by Stage of Development 17
5 Minimally Invasive Surgical (MIS) Devices Companies and Product Overview 18
5.1 Actuated Medical, Inc. Company Overview 18
5.1.1 Actuated Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 BriteSeed Company Overview 20
5.2.1 BriteSeed Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 Delft University of Technology Company Overview 21
5.3.1 Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 DistalMotion Company Overview 24
5.4.1 DistalMotion Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 ES Vascular Ltd. Company Overview 26
5.5.1 ES Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 26
5.6 Ethicon Endo-Surgery, Inc. Company Overview 27
5.6.1 Ethicon Endo-Surgery, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 Eximis Company Overview 28
5.7.1 Eximis Pipeline Products & Ongoing Clinical Trials Overview 28
5.8 FlexDex Company Overview 29
5.8.1 FlexDex Pipeline Products & Ongoing Clinical Trials Overview 29
5.9 Fortimedix B.V. Company Overview 31
5.9.1 Fortimedix B.V. Pipeline Products & Ongoing Clinical Trials Overview 31
5.10 Hadassah Medical Center Company Overview 32
5.10.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 32
5.11 Human Extensions LTD Company Overview 33
5.11.1 Human Extensions LTD Pipeline Products & Ongoing Clinical Trials Overview 33
5.12 Imperial College London Company Overview 34
5.12.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 34
5.13 John Hopkins University Company Overview 35
5.13.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 35
5.14 Osaka University Company Overview 36
5.14.1 Osaka University Pipeline Products & Ongoing Clinical Trials Overview 36
5.15 Rambam Health Care Campus Company Overview 37
5.15.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 37
5.16 Signum Surgical Ltd Company Overview 38
5.16.1 Signum Surgical Ltd Pipeline Products & Ongoing Clinical Trials Overview 38
5.17 Technische Universiteit Eindhoven Company Overview 39
5.17.1 Technische Universiteit Eindhoven Pipeline Products & Ongoing Clinical Trials Overview 39
5.18 UltraSurge Technologies Ltd. Company Overview 40
5.18.1 UltraSurge Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40
5.19 University of California, San Francisco Company Overview 41
5.19.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 41
5.20 University of Wisconsin Madison Company Overview 45
5.20.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 45
5.21 Varada Innovations Inc. Company Overview 47
5.21.1 Varada Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.22 VenX Medical LLC Company Overview 48
5.22.1 VenX Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 48
5.23 XACT Robotics Ltd. Company Overview 51
5.23.1 XACT Robotics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 51
6 Minimally Invasive Surgical (MIS) Devices- Recent Developments 52
6.1 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 52
6.2 Oct 26, 2016: Life Spine Achieves 32% Sales Growth and Announces Industry’s Largest Post-Packing Capabilities for Lateral Fusion 52
6.3 Oct 18, 2016: Intuitive Surgical Announces Third Quarter Earnings 53
6.4 Oct 17, 2016: Fortimedix Surgical Announces the U.S. Launch of symphonX Surgical Platform, the World’s Lowest Profile Single-Port Surgery Solution, During American College of Surgeons Clinical Congress 2016 54
6.5 Oct 17, 2016: Syneron Medical Strengthens Senior Management Team 54

Access Report @ https://www.wiseguyreports.com/reports/729487-minimally-invasive-surgical-mis-devices-medical-devices-pipeline-assessment-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Pharma Parallel Trade: Beyond Brexit and EU Falsified Medicine Directive

Parallel Trade 2017

SMi Group (2016.11.16 London) Over 90 senior leaders in parallel trade will meet in London in February 2017 to discuss upcoming trends and share best practices.

The best Parallel Trade conference of the last 5 years!

— Past Attendee of Parallel Trade 2016

LONDON, LONDON, UNITED KINGDOM, November 16, 2016 /EINPresswire.com/ — With Brexit and the new EU Falsified Medicine Directive, what does the future hold for parallel trade? SMi’s Parallel Trade conference will be returning to London next February 6th-7th, for its 11th year, to discuss short term and long term concerns of pharma manufacturers, regulators and parallel traders. They will engage in an interactive debate and discuss how to keep abreast of the current trends and how to overcome all challenges.

Parallel Trade 2017 official website is www.parallel-trade.com/EIN

Dr Rick Greville, Director Wales and Director Distribution & Supply for The Association of the British Pharmaceutical Industry will be speaking on “The European Commission's Falsified Medicines Directive – recent updates”. Dr. Gr0eville will discuss what progress has been made since February 2016 and what the market participants need to know about "product information templates", and much more.

Other key topics to be discussed during the 2-day conference are: What will Brexit mean for parallel trade to and from the UK? Parallel Trade 101 – Which factors determine the flow of pharmaceutical products in Europe? Beyond pharmaceutical products – parallel imports of medical devices. The Patient’s perspective.

The event programme also features three panel debates on: Shortages; Challenges and opportunities for parallel traders; Technology & new trends; and two exclusive post conference workshops on “Understanding IP and competition law issues in parallel trade” (Hosted by Kathy Osgerby, Associate and Karoline Zwierzynska, Associate, Arnold & Porter (UK) LLP) and “Parallel Trade – Management Strategies” (Hosted by Janice Haigh, Practice Leader, Market Access, Quintiles).

For further information please refer to www.parallel-trade.com/EIN

Expert Speakers Line up for 2017 includes: The Association of the British Pharmaceutical Industry (Dr Rick Greville, Director Distribution & Supply), Shire International GmbH (Eric Noehrenberg, Director, Regional Market Access Lead, Latin America), Delfarma (Tomasz Dzitko, President), European Association for Euro-Pharmaceutical Companies (Heinz Kobelt, Director European Affairs), ISPOR (Vladimir Zah, Health Economics Consultant), Abacus Medicine (Flemming Wagner, CEO), IMS Health (Alexey Savin, Principal Russia and CIS), Arnold & Porter (UK) LLP (Kathy Osgerby, Associate, and Karoline Zwierzynska, Associate), Europe Economics (Dermot Glynn, Senior Advisor), European Alliance for Access to Save Medicines (Mike Isles, Executive Director), Research Health (Dr Andrew Stainthorpe, Director Market Access and Managed Entry) and many more.

The complete 2-day event programme is available for complimentary download at www.parallel-trade.com/EIN
Latest confirmed attendees include senior representatives from Astellas Pharma, AstraZeneca, Teva UK, Vifor Pharma, Janssen Pharmaceutica NV, Napp Laboratories, Kantar Health, Ferring Pharmaceuticals, LEO Pharma, AstraZeneca Czech Republic, Swedish Orphan Biovitrum AB, Amgen, Novartis Pharmaceuticals, Novartis Turkey, LEO Pharma, Johnson & Johnson, Novo Nordisk Pharma, Daiichi Sankyo Europe GmbH, Sunovion Pharmaceuticals Europe Ltd and many more.
Feedback from past attendees of SMi Group’s Parallel Trade: “Interesting conference, generating a good debate from all sides”, “Great conference! Audience very enthusiastic and actively participating in discussions”, “Very good discussing about pricing issues and competition”, “Overall, a very positive experience!”, “The best Parallel Trade conference of the last 5 years!”.

11th annual Parallel Trade
6-7 February 2017, Holiday Inn Kensington Forum, London, UK
www.parallel-trade.com/EIN
Sponsorship, Exhibition contact: Alia Malick, +44 (0) 207 827 6168, amalick@smi-online.co.uk
Delegates/Group contact: Fateja Begum, +44 (0) 207 827 6184, fbegum@smi-online.co.uk
Media Contact: jrotar@smi-online.co.uk
______________________________end of press-release______________________
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Julia Rotar
SMi Group
2078276088
email us here

Source: EINPresswire.com

Nano Titanium Dioxide Market – Opportunities and Forecast 2016 – 2021

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — Nano Titanium Dioxide Market

This report studies Nano Titanium Dioxide in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Sigma-Aldrich
US Research Nanomaterials, Inc.
Showa America
Gerhold Chemetals Co., Ltd
EPRUI Nanoparticles & Microspheres Co. Ltd
Green Earth Nano Science Inc.
Henan Huier Nano-Technology co.,Ltd
Xuan Cheng Jing Rui New Material Co.,Ltd
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Nano Titanium Dioxide in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India

Request Sample Report @ https://www.wiseguyreports.com/sample-request/743254-global-nano-titanium-dioxide-market-research-report-2016

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by application, this report focuses on consumption, market share and growth rate of Nano Titanium Dioxide in each application, can be divided into
Photocatalyst
Cosmetics
Automotive Topcoat
Other

Complete Report Details @ https://www.wiseguyreports.com/reports/743254-global-nano-titanium-dioxide-market-research-report-2016

Table of Contents

Global Nano Titanium Dioxide Market Research Report 2016
1 Nano Titanium Dioxide Market Overview
1.1 Product Overview and Scope of Nano Titanium Dioxide
1.2 Nano Titanium Dioxide Segment by Type
1.2.1 Global Production Market Share of Nano Titanium Dioxide by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Nano Titanium Dioxide Segment by Application
1.3.1 Nano Titanium Dioxide Consumption Market Share by Application in 2015
1.3.2 Photocatalyst
1.3.3 Cosmetics
1.3.4 Automotive Topcoat
1.3.5 Other
1.4 Nano Titanium Dioxide Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Nano Titanium Dioxide (2011-2021)

2 Global Nano Titanium Dioxide Market Competition by Manufacturers
2.1 Global Nano Titanium Dioxide Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 Global Nano Titanium Dioxide Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Nano Titanium Dioxide Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Nano Titanium Dioxide Manufacturing Base Distribution, Sales Area and Product Type
2.5 Nano Titanium Dioxide Market Competitive Situation and Trends
2.5.1 Nano Titanium Dioxide Market Concentration Rate
2.5.2 Nano Titanium Dioxide Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Nano Titanium Dioxide Capacity, Production, Revenue (Value) by Region (2011-2016)
3.1 Global Nano Titanium Dioxide Capacity and Market Share by Region (2011-2016)
3.2 Global Nano Titanium Dioxide Production and Market Share by Region (2011-2016)
3.3 Global Nano Titanium Dioxide Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global Nano Titanium Dioxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America Nano Titanium Dioxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Nano Titanium Dioxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Nano Titanium Dioxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Nano Titanium Dioxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Southeast Asia Nano Titanium Dioxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India Nano Titanium Dioxide Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Nano Titanium Dioxide Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Nano Titanium Dioxide Consumption by Regions (2011-2016)
4.2 North America Nano Titanium Dioxide Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Nano Titanium Dioxide Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Nano Titanium Dioxide Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Nano Titanium Dioxide Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Nano Titanium Dioxide Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Nano Titanium Dioxide Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Nano Titanium Dioxide Production, Revenue (Value), Price Trend by Type
5.1 Global Nano Titanium Dioxide Production and Market Share by Type (2011-2016)
5.2 Global Nano Titanium Dioxide Revenue and Market Share by Type (2011-2016)
5.3 Global Nano Titanium Dioxide Price by Type (2011-2016)
5.4 Global Nano Titanium Dioxide Production Growth by Type (2011-2016)

..……CONTINUED

For more information or any query mail at sales@wiseguyreports.com

Check Discount on This Report @ https://www.wiseguyreports.com/check-discount/743254-global-nano-titanium-dioxide-market-research-report-2016

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

ABOUT US:

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

MediPoint: Body Contouring – Global Analysis and Market Forecasts



Wise.Guy.

MediPoint: Body Contouring – Global Analysis and Market Forecasts

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — Body contouring devices are categorized into the following segments: minimally invasive body contouring devices and non-invasive body contouring devices.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/729484-medipoint-body-contouring-global-analysis-and-market-forecasts

Minimally invasive body contouring devices include –
– Laser-Assisted Liposuction Devices
– Radiofrequency Assisted Liposuction Devices
– Ultrasound Assisted Liposuction Devices
– Power Assisted Liposuction Devices

Non-invasive body contouring devices include –
– Radiofrequency Energy Devices
– High-Intensity Focused Ultrasound Devices
– Cryolipolysis Devices

Growth in the body contouring devices market is driven primarily by the growing non-invasive devices segment, an increasing global obesity rate, and the aging population.

The global market for body contouring devices is led by Syneron Candela, Cynosure, Solta Medical, and Zeltiq Aesthetics.

Key Questions Answered
– What are the unmet needs with the current generation of devices? Device Effectiveness? Device Efficiency?
– With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global body contouring device market?
– What trends and events are affecting the global market?
– Which are the key, high growth markets that device manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products?

Scope
– Competitive assessment: Currently marketed body contouring devices and evolving competitive landscape
– In-depth analysis of unmet needs and adoption trends of different body contouring devices
– Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications
– Annualized total body contouring devices market revenue by segment and market outlooks by country from 2013-2022.
– Other key topics covered include strategic competitive assessment, market characterization, identification of unmet needs, market dynamics, and implications of the emerging technologies on the market.

The report will enable you to –
– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
– Develop business strategies by understanding the trends shaping and driving the global body contouring devices market.
– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global body contouring devices market in the future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
– Track device sales in the global and country-specific body contouring devices market from 2013-2022.
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 12
2 Introduction 14
2.1 Catalyst 14
2.2 Related Reports 15
3 Market Access 16
3.1 Reimbursement 16
3.2 Regulatory Issues/Recalls 16
3.3 Mergers and Acquisitions 17
3.3.1 The Lumenis Acquisition of Pollogen 18
3.3.2 The Valeant Acquisition of Solta Medical 18
3.3.3 The Cynosure Acquisition of Palomal Medical Technologies 18
3.3.4 The Fosun Acquisition of Alma Lasers 18
3.3.5 The Solta Medical Acquisition of Sound Surgical Technologies 18
4 Unmet Needs 19
4.1 Overview 19
4.2 Understanding of longterm outcomes for newer methods 19
4.3 Understanding the Clinical Outcomes of Combining Multiple Treatment Types 19
4.4 Clinical Measures of Procedure Effectiveness 19
4.5 Procedure Efficiency 20
4.6 Minimizing Post-Procedural Downtime 20
5 Competitive Assessment 21
5.1 Company Share Analysis 21
5.2 Major Players 22
5.2.1 Alma Lasers 22
5.2.2 Cutera 25
5.2.3 CynoSure 27
5.2.4 DEKA 29
5.2.5 Invasix Aesthetic Solutions 31
5.2.6 Lumenis 33
5.2.7 Syneron Candela 37
5.2.8 Solta Medical 39
5.2.9 Venus Concept 42
5.2.10 Zeltiq 44
6 Market Outlooks 47
6.1 Procedure Trends 47
6.2 Market Drivers and Barriers 48
6.2.1 Market Driver: Non-surgical Options 48
6.2.2 Market Driver: Men Getting More Cosmetic Surgery 49
6.2.3 Market Driver: Obesity 49
6.2.4 Market Driver: The Aging Population 49
6.2.5 Market Barrier: No Reimbursement 50
6.2.6 Market Barrier: Alternative Treatment Options 50
6.2.7 Market Barrier: Complications 51
6.2.8 Multiple Treatments Required 52
6.3 Market Outlooks by Segment 52
6.3.1 Minimally Invasive Body Contouring Devices 53
6.3.2 Non-invasive Body Contouring Devices 63
6.4 Market Outlooks by Geography 70
6.4.1 Global 70
6.4.2 Europe 72
6.4.3 Asia-Pacific 82
6.4.4 North America 91
6.4.5 South America 96
7 Appendix 98
7.1 Bibliography 98
7.2 Abbreviations 104
7.3 Methodology 105
7.4 Forecasting Methodology 106
7.4.1 Average Selling Prices 106
7.4.2 Market Segmentation 106
7.4.3 Company Share 106
7.5 Primary Research Efforts 107
7.6 About the Authors 108
7.6.1 Brigitte Babin, MSc, Analyst, Medical Devices 108
7.6.2 Linda Tian, MSc, Managing Analyst, Medical Devices 108

Access Report @ https://www.wiseguyreports.com/reports/729484-medipoint-body-contouring-global-analysis-and-market-forecasts

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Sports Watches Market By Applications,Types,Regions And Companies Market Research Report To 2021



Wise.Guy.

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ —

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/744091-global-sports-watches-market-research-report-2016

This report studies Sports Watches in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
CASIO
GARMIN
Suunto
Citizen
EZON
Nike
ADIDAS
Seiko
Fossil
Fitbit
SKMEI
Polar
Nike
EPSON
KAHUNA
LOTUS
TIMEX
Hanowa
Motorola
Apple
TomTom
SWISS EAGLE
NAUTICA

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Sports Watches in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III

Split by application, this report focuses on consumption, market share and growth rate of Sports Watches in each application, can be divided into
Application 1
Application 2
Application 3

Complete Report Details @ https://www.wiseguyreports.com/reports/744091-global-sports-watches-market-research-report-2016

Table of Contents

Global Sports Watches Market Research Report 2016

1 Sports Watches Market Overview
1.1 Product Overview and Scope of Sports Watches
1.2 Sports Watches Segment by Type
1.2.1 Global Production Market Share of Sports Watches by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Sports Watches Segment by Application
1.3.1 Sports Watches Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Sports Watches Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Sports Watches (2011-2021)

2 Global Sports Watches Market Competition by Manufacturers
2.1 Global Sports Watches Production and Share by Manufacturers (2015 and 2016)
2.2 Global Sports Watches Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Sports Watches Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Sports Watches Manufacturing Base Distribution, Sales Area and Product Type
2.5 Sports Watches Market Competitive Situation and Trends
2.5.1 Sports Watches Market Concentration Rate
2.5.2 Sports Watches Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Sports Watches Production, Revenue (Value) by Region (2011-2016)
3.1 Global Sports Watches Production by Region (2011-2016)
3.2 Global Sports Watches Production Market Share by Region (2011-2016)
3.3 Global Sports Watches Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global Sports Watches Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America Sports Watches Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Sports Watches Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Sports Watches Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Sports Watches Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Southeast Asia Sports Watches Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India Sports Watches Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Sports Watches Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Sports Watches Consumption by Regions (2011-2016)
4.2 North America Sports Watches Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Sports Watches Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Sports Watches Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Sports Watches Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Sports Watches Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Sports Watches Production, Consumption, Export, Import by Regions (2011-2016)

……….

7 Global Sports Watches Manufacturers Profiles/Analysis
7.1 CASIO
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Sports Watches Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 CASIO Sports Watches Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 GARMIN
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Sports Watches Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 GARMIN Sports Watches Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Suunto
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Sports Watches Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Suunto Sports Watches Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Citizen
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Sports Watches Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II

…..Continued

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=744091

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Pancreatic Cancer Market Global Industry Analysis 2016

“Pancreatic Cancer -Pipeline Insights, 2016”, report provides comprehensive insights about pipeline drugs across this indication

PUNE, INDIA , November 16, 2016 /EINPresswire.com/ — Global Pancreatic Cancer Market

Summary

DelveInsight’s, “Pancreatic Cancer -Pipeline Insights, 2016”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all 103 pipeline drugs that fall under the category of Pancreatic Cancer.
Recent report of Delveinsight covers drugs that are being developed with novel approach to target or intervene along the pathways of tumorigenesis. Among the pipeline agents NewLink Genetics Corporation’s algenpantucel-L is expected to be the frontrunner amongst all other drugs. The therapeutic candidate has also received fast Track and orphan drug designations from the FDA and is expected to launch in both the resectable and unresectable locally-advanced settings.
The report also provides a comparative analysis of therapeutics based on the molecule type, route of administration, etc. It also gives insights of other activities such as, agreements, joint ventures, partnerships, acquisitions and mergers.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/476527-pancreatic-cancer-pipeline-insights-2016

Scope:

The new report, provides a Pancreatic Cancer Landscape across the globe
• The report provides drug profiles which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, Preclinical and Discovery stages
• Coverage of the Pancreatic Cancer pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Pancreatic Cancer and also provide company profiling
• Pipeline products coverage based on various stages of development from NDA filings to discovery.
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type.
Access Complete Report @ https://www.wiseguyreports.com/reports/476527-pancreatic-cancer-pipeline-insights-2016

Reasons to Buy

Complete Pipeline intelligence and complete understanding over therapeutics development for Pancreatic Cancer
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding Pancreatic Cancer pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions
Table of Contents:

Pancreatic Cancer Overview
• Pancreatic Cancer Types:
• Epidemiology:
• Market Scenario:
• Pipeline Therapeutics
• An Overview of Pipeline Products for Pancreatic Cancer
• Therapeutics under Development by Companies
• Late Stage Products (Filed and Phase III)
• Comparative Analysis
• Mid Stage Products (Phase II)
• Comparative Analysis
• Early Stage Products (Phase I and IND)
• Comparative Analysis
• Discovery and Pre-clinical stage Products
• Comparative Analysis
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Discontinued Products
• Dormant Products
• Companies involved in Therapeutics Development
• Appendix
• Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
• Contact Us
List of Tables:

Table 1: Number of Products Under Development for Pancreatic Cancer 2016
• Table 2: Number of Products under Development by Companies, 2016
• Table 3: Last Stage Products (Phase III and Filed), 2016
• Table 4: Mid Stage Products (Phase II), 2016
• Table 5: Early Stage Products (Phase I and IND), 2016
• Table 6: Phase 0 stage Products, 2016
• Table 7: Discovery and Pre-clinical Stage Products, 2016
• Table 8: Assessment by Monotherapy Products, 2016
• Table 9: Assessment by Route Of Administration, 2016
• Table 10: Assessment by Stage and Route Of Administration, 2016
• Table 11: Assessment by Molecule Type, 2016
• Table 12: Assessment by Stage and Molecule Type, 2016
• Table 13: Discontinued Products, 2016
• Table 14: Dormant Products, 2016
• Table 15: Companies Involved in Therapeutic Development, 2016
List of Figures:

Figure 1: Number of Products under Development for Pancreatic Cancer, 2016
• Figure 2: Late Stage Products (Filed and Phase III), 2016
• Figure 3: Mid Stage Products (Phase II), 2016
• Figure 4: Early Stage Products (Phase I and IND), 2016
• Figure 5: Discovery and Pre-clinical Stage Products, 2016
• Figure 6: Assessment by Monotherapy Products, 2016
• Figure 7: Assessment by Combination Products, 2016
• Figure 8: Assessment by Route of Administration, 2016
• Figure 9: Assessment by Stage and Route of Administration, 2016
• Figure 10: Assessment by Molecule Type, 2016
• Figure 11: Assessment by Stage and Molecule Type, 2016
Buy Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=476527

For more information or any query mail at sales@wiseguyreports.com

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com

Germany Power Market Outlook to 2030, Update 2016: Market Trends, Regulations, and Competitive Landscape



Wise.Guy.

Germany Power Market Outlook to 2030, Update 2016 Market Trends, Regulations, and Competitive Landscape

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ — This report elaborates Germany's power market structure and provides historical and forecast numbers for capacity, generation, and consumption up to 2030. Detailed analysis of the Germany power market’s regulatory structure, import and export trends, competitive landscape, and power projects at various stages of the supply chain is provided. The report also gives a snapshot of the power sector in Germany on broad parameters of macroeconomics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario, and future potential. Financial performance of the leading power companies is also analyzed in the report.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/729541-germany-power-market-outlook-and-competitive-landscape

Scope
– Snapshot of the country’s power sector across parameters – macro economics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario and future potential of the power sector.
– Statistics for installed capacity, power generation and consumption from 2000 to 2015, forecast for the next 15 years to 2030.
– Break-up by technology, including thermal, hydro, renewable and nuclear
– Data on leading current and upcoming projects.
– Information on grid interconnectivity, transmission and distribution infrastructure and power exports and imports.
– Policy and regulatory framework governing the market.
– Detailed analysis of top market participant, including market share analysis and SWOT analysis.

Reasons to buy
– Identify opportunities and plan strategies by having a strong understanding of the investment opportunities in the country’s power sector
– Identification of key factors driving investment opportunities in the country’s power sector
– Facilitate decision-making based on strong historic and forecast data
– Develop strategies based on the latest regulatory events
– Position yourself to gain the maximum advantage of the industry’s growth potential
– Identify key partners and business development avenues
– Identify key strengths and weaknesses of important market participants
– Respond to your competitors’ business structure, strategy and prospects.

Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 10
2.1 GlobalData Report Guidance 11
3 Germany, Power Market, Snapshot 12
3.1 Germany, Power Market, Macroeconomic Factors 12
3.2 Germany, Power Market, Supply Security 14
3.3 Germany, Power Market, Opportunities 15
3.4 Germany, Power Market, Challenges 15
4 Germany, Power Market, Market Analysis 17
4.1 Germany, Power Market, Supply Structure 17
4.2 Germany, Power Market, Key Market Players 17
4.3 Germany, Power Market, Financial Deals 18
4.3.1 Deal Volume and Value Analysis, 2004-August 2016 18
4.3.2 Deals by Type, 2015 20
4.4 Germany, Power Market, Demand Structure 21
4.4.1 Germany, Consumption by Sector, 2015 23
5 Germany, Power Market, Regulatory Scenario 24
5.1 Germany, Power Market, Key Electricity Policies 24
5.1.1 Amendment of German Act against Restraints on Competition 25
5.1.2 Amendment of German Energy Act 26
5.1.3 Large Combustion Plant Directive 26
5.1.4 Amendment of German Greenhouse Gas Emission Trading Law 27
5.1.5 Target Grid 2050 27
5.1.6 Renewable Energy Policies 28
5.1.7 Subsidy for Solar Photovoltaic with Storage Installations 29
5.1.8 Nuclear Energy Policies 29
5.1.9 Initiatives to Reduce Greenhouse and Carbon Dioxide Emissions 30
6 Germany, Power Market, Capacity and Generation Overview 31
6.1 Germany, Power Market, Cumulative Installed Capacity, by Fuel Type, 2015 31
6.2 Germany, Power Market, Cumulative Installed Capacity and Annual Power Generation, 2000-2030 32
6.2.1 Cumulative Installed Thermal Capacity and Annual Thermal Power Generation, 2000-2030 35
6.2.2 Cumulative Installed Hydropower Capacity and Annual Hydropower Generation, 2000-2030 39
6.2.3 Cumulative Installed Nuclear Capacity and Annual Nuclear Power Generation, 2000-2030 43
6.2.4 Cumulative Installed Non-hydro Renewable Capacity and Annual Non-hydro Renewable Power Generation, 2000-2030 46
7 Germany, Power Market, Transmission and Distribution Overview 50
7.1 Germany, Power Market, Transmission Overview 50
7.2 Germany, Power Market, Distribution Overview 51
7.3 Germany, Power Market, Grid Interconnection 52
7.3.1 Electricity Import and Export Trends, 2000-2015 54
7.4 Germany, Power Market, Electricity Trading 55
8 Germany, Power Market, Competitive Landscape: Snapshot of Leading Power Generation Companies 56
8.1 Key Company in the Germany Power Market – RWE AG 56
8.1.1 Business Description 56
8.1.2 SWOT Overview 57
8.2 Key Company in the Germany Power Market – E.ON SE 60
8.2.1 Company Overview 60
8.2.2 Business Description 60
8.2.3 SWOT Overview 61
8.3 Key Company in the Germany Power Market – Vattenfall AB 64
8.3.1 Company Overview 64
8.3.2 Business Description 64
8.3.3 SWOT Overview 65
8.4 Key Company in the Germany Power Market – EnBW 68
8.4.1 Company Overview 68
8.4.2 Business Description 68
8.4.3 SWOT Overview 70

Access Report @ https://www.wiseguyreports.com/reports/729541-germany-power-market-outlook-and-competitive-landscape

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: EINPresswire.com